Rotavirus: Disease and vaccine update, 2007

Journal of Family Practice

Volumn 56, Issue SUPPL. 2, 2007, Pages

  Stebbins, Samuel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

CLINICAL TRIAL; DEATH; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; FEVER; FOOD AND DRUG ADMINISTRATION; HIGH RISK POPULATION; HUMAN; INTUSSUSCEPTION; IRRITABILITY; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; ROTAVIRUS; SIDE EFFECT; SYSTEMATIC REVIEW; VIRUS INFECTION; VOMITING;

ADULT; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTUSSUSCEPTION; MALE; PRACTICE GUIDELINES; PREGNANCY; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES; VACCINES, ATTENUATED;

EID: 33847135174     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Parashar UD, Gibson CJ, Bresse JS, Glass RL. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12:304-306.
2. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565-572.
3. Rotavirus Vaccine Program. Rotavirus facts. January 2006. Available at: http://www.rotavirusvaccine.org/rotavirus-facts.htm. Accessed October 20, 2006.
4. Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet. 1973;2:1281-1283.
5. Bresee JS, Hummelman E, Nelson EAS, Glass, RI. Rotavirus in Asia. The Value of Surveillance for Monitoring Decisions about the Introduction of New Vaccines. J Infect Dis. 2005;192(suppl 1) S1-5. Available at: http://www.journals.uchicago.edu/JID/journal/issues/v192nS1/33792/33792.web.pdf. Accessed October 20, 2006.
6. Bresee JS, Parashar UD, Widdowson MA, Gentsch JR, Steele AD, Glass RI. Update on rotavirus vaccines. Pediatr Infect Dis J. 2005;24;947-952.
7. Turcios RM, Curns AT, Holman RC, et al; for the National Respiratory and Enteric Virus Surveillance System Collaborating Laboratories. Temporal and geographic trends of rotavirus activity in the United States, 1997-2004. Pediatr Infect Dis J. 2006;25:451-454.
8. Desselberger U, Wolleswinkel-van den Bosch J, Mrukowicz J, Rodrigo C, Giaquinto C, Vesikari T. Rotavirus types in Europe and their significance for vaccination. Pediatr Infect Dis J. 2006;25(suppl):S30-S41.
9. Gleizes O, Desselberger U, Tatochenko V, et al. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J. 2006;25(suppl):S12-S21.
10. Ansari SA, Sattar SA, Springthorpe VS, Wells GA, Tostowaryk W. Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J Clin Microbiol. 1988;26:1513-1518.
11. Zerr DM, Allpress AL, Heath J, Bornemann R, Bennett E. Decreasing hospital-associated rotavirus infection: a multidisciplinary hand hygiene campaign in a children's hospital. Pediatr Infect Dis J. 2005;24:397-403.
12. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med. 1996;335:1022-1028.
13. Matson DO; for the National Foundation for Infectious Diseases. Clinical updates in pediatric infectious diseases. Current status of rotavirus immunization. September 1997;2(4). Available at: http://www.nfid.org/%5Fold/ publications/clinicalupdates/pediatric/rotavirus.html. Accessed October 20, 2006.
14. Centers for Disease Control and Prevention (CDC). Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 1999;48:577-581. Available at: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm4827a1.htm. Accessed October 20, 2006.
15. Weijer C. The future of research into rotavirus vaccine. BMJ. 2000;321:525-526.
16. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
17. Ruiz-Palacios GM, Pérez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
18. Parashar UD, Alexander JP, Glass RI; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1-13.